Article
Identification of genetic variants in the human thromboxane synthase gene (CYP5A1).
Mutation research - 1 Jan 2001
Chevalier D, Lo-Guidice J M, Sergent E, Allorge D, Debuysère H, Ferrari N, Libersa C, Lhermitte M, Broly F
Abstract excerpt
Thromboxane synthase (CYP5A1) catalyzes the conversion of prostaglandin H2 to thromboxane A2, a potent mediator of platelet aggregation, vasoconstriction and bronchoconstriction. It has been implicated in the patho-physiological process of a variety of diseases, such as atherosclerosis, myocardial infarction, stroke and asthma. On the basis of the hypothesis that variations of the CYP5A1 gene may play an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
